Although about 1 in 8 men in the U.S. will be diagnosed with prostate cancer during their lifetime, only about 1 in 44 will die from it. Most men diagnosed with prostate cancer die from other causes, ...

Prostate cancer comes in all kinds of varieties, from serious and life-threatening cases all the way to the more common, nonaggressive forms that are typically age related. The disease tends to occur ...

Patients with favorable-risk prostate cancer “should be aware that they don't need treatment right away,” one expert said. Active surveillance has been shown to be an effective management strategy for ...

Until improvements under development can be broadly implemented, routine confirmatory testing in active surveillance for ...

Clinicians must appropriately assess life expectancy and take steps to avoid prostate cancer overtreatment. Even in the active surveillance era, overtreatment persists among men with limited life ...

Half of men with low-risk prostate cancer remained free from progression or treatment 10 years after diagnosis when followed in a protocol-directed active surveillance program. At 10 years, 43% of ...

Please provide your email address to receive an email when new articles are posted on . Urologists more often recommend active surveillance over treatment for low-risk prostate cancer. Patients’ ...

A cancer diagnosis is serious, but immediately starting treatment sometimes isn't the best course of action. ljubaphoto/E+ via Getty Images Although about 1 in 8 men in the U.S. will be diagnosed with ...

Confirmatory or systematic prostate biopsies may be unnecessary for men considering active surveillance for prostate cancer who have negative findings on multiparametric MRI scans. Multiparametric MRI ...

MRI does not reliably exclude clinically significant prostate cancer in about one quarter of patients receiving active surveillance, confirming that MRI is not a substitute for biopsy.

There are risks of patients with prostate cancer being over- and under-treated, which is why speaking to a team of doctors is important, an expert said. For patients who recently received a diagnosis ...

A groundbreaking trial for a prostate cancer treatment with fewer side effects has launched in the UK. Backed by the ...